Skip to content

Retrospective cohort study of alveolar ridge preservation

Multidimensional outcome evaluation and exploration of indications for micro crestal flap-alveolar ridge preservation in molar extraction sites with severe periodontitis: Retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098735
Enrollment
Unknown
Registered
2025-03-13
Start date
2025-03-30
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontitis

Interventions

natural healing group:NA
Micro crestal flap-alveolar ridge preservation group:NA

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. molars extracted due to severe periodontitis or combined periodontal-endodontic lesions; 2. Having a complete medical history, including records of the full mouth periodontal condition at initial consultation; 3. Patients meet the diagnostic criteria for stage III/IV periodontitis; 4. Signed written informed consent prior to treatment for the use of radiographic and clinical data for clinical research; 5. The affected tooth should receive either alveolar ridge preservation or natural healing. In cases of alveolar ridge preservation, the biomaterials used should be deproteinized bovine bone mineral particles, resorbable collagen membranes, and collagen sponge dressings, with flaps confined to the apex of the alveolar ridge without wound closure (micro crestal flap - alveolar ridge preservaiton). 6. CBCT was taken by NewTom VG (Aperio Services, Italy) at 110 kV, 12-17 mA, with an imaging thickness of 0.125 -0.300 mm.

Exclusion criteria

Exclusion criteria: 1. Patients are <18 years of age; 2. Patients were pregnant or breastfeeding at the time of surgery; 3. Patients suffering from systemic diseases or using drugs affecting bone metabolism (bisphosphonates, glucocorticoids, etc.) in the perioperative period; 4. A history of head and neck radiotherapy; 5. Smoking more than 10 cigarettes per day; 6. The affected tooth was extracted due to untreatable endodontic disease or tooth fracture;

Design outcomes

Primary

MeasureTime frame
Central bone height;Ridge width at 1 mm apically from higher alveolar ridge;

Secondary

MeasureTime frame
General information of affected teeth;General information of patients;Bone augmentation procedures during implant therapy;Lingual bone height;Buccal bone height;Ridge width at 3 mm apically from higher alveolar ridge;Ridge width at 1 mm apically from lower alveolar ridge;Ridge width at 3 mm apically from lower alveolar ridge;modified implant plaque index;Peri-implant probing depth;Modified bleeding index;Keratinized tissue width;Radiographic Bone Loss;

Countries

China

Contacts

Public ContactHaoyun Zhang

Peking University Hospital of Stomatology

zhy2313pku@163.com+86 10 82195368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026